ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 29 filers reported holding ACER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $671,000 | – | 21,773 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 143,000 | $2,877,000 | 2.19% |
| Vivo Capital, LLC | 579,051 | $11,651,000 | 1.49% |
| Nantahala Capital Management | 903,455 | $18,178,000 | 0.56% |
| HEARTLAND ADVISORS INC | 220,000 | $4,426,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 388,712 | $7,821,000 | 0.34% |
| Avoro Capital Advisors LLC | 150,000 | $3,018,000 | 0.18% |
| Monashee Investment Management LLC | 11,364 | $229,000 | 0.16% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 125,000 | $2,515,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 20,000 | $402,000 | 0.10% |
| 683 Capital Management, LLC | 19,367 | $390,000 | 0.02% |